Back to discover
Disease

Bartter Syndrome

Emerging research
MeSHBartter Syndrome
1
Publications
2017
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes1
  • Dietary Supplements1
Leading journals1
  • Kidney international1
Leading researchers8
  • Blanchard A1
  • Bockenhauer D1
  • Bolignano D1
  • Calò LA1
  • Cosyns E1
  • Devuyst O1
  • Ellison DH1
  • Karet Frankl FE1
Affiliations (unnormalised)6
  • Center for Molecular Medicine1
  • Centre d'Investigation Clinique1
  • Centre for Nephrology1
  • Institute of Clinical Physiology1
  • Institute of Physiology1
  • Oregon Health and Science University1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A group of disorders caused by defective salt reabsorption in the ascending LOOP OF HENLE. It is characterized by severe salt-wasting, HYPOKALEMIA; HYPERCALCIURIA; metabolic ALKALOSIS, and hyper-reninemic HYPERALDOSTERONISM without HYPERTENSION. There are several subtypes including ones due to mutations in the renal specific SODIUM-POTASSIUM-CHLORIDE SYMPORTERS.

Identifiers
MeSHBartter Syndrome
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.